Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

(2018) Jake S. O’Donnell et al.   SEMINARS IN CANCER BIOLOGY

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

(2017) Jacob Schachter et al.   LANCET

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

(2017) Felix Sahm et al.   LANCET ONCOLOGY

Diagnostic challenges in meningioma

(2017) Martha Nowosielski et al.   NEURO-ONCOLOGY

B7-H3 Augments Inflammatory Responses and Exacerbates Brain Damage via Amplifying NF-κB p65 and MAPK p38 Activation during Experimental Pneumococcal Meningitis

(2017) Xuqin Chen et al.   PLoS One

B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway

(2017) Yuchao Li et al.   Journal of Cancer

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer

(2017) Yohei Masugi et al.   Cancer Immunology Research

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Genetic landscape of meningioma

(2016) Sayaka Yuzawa et al.   Brain Tumor Pathology

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

(2016) E. Picarda et al.   CLINICAL CANCER RESEARCH

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

(2016) Seunggu J. Han et al.   JOURNAL OF NEURO-ONCOLOGY

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis

(2016) B Benzon et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

(2016) Chia-Wei Li et al.   Nature Communications

Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors

(2016) Caroline E. Nunes-Xavier et al.   Oncotarget

Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway

(2016) Chao Xie et al.   Scientific Reports

Regulation of PD-L1: a novel role of pro-survival signalling in cancer

(2015) J. Chen et al.   ANNALS OF ONCOLOGY

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

(2015) Kristin J. Lastwika et al.   CANCER RESEARCH

Mast cells in meningiomas and brain inflammation

(2015) Stavros Polyzoidis et al.   Journal of Neuroinflammation

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy

(2015) W. Peng et al.   Cancer Discovery

ARID1A and TERT promoter mutations in dedifferentiated meningioma

(2015) Malak S. Abedalthagafi et al.   Cancer Genetics

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma

(2015) Ziming Du et al.   Oncotarget

Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB

(2015) Kavitha Gowrishankar et al.   PLoS One

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome

(2014) Vibeke A Ingebrigtsen et al.   BMC CANCER

Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer

(2014) Jillian Brechbiel et al.   CANCER TREATMENT REVIEWS

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

(2014) Roy S. Herbst et al.   NATURE

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas

(2014) MATEUSZ BUJKO et al.   Oncology Letters

A Review of Stereotactic Radiosurgery Practice in the Management of Skull Base Meningiomas

(2014) Elena Vera et al.   Journal of Neurological Surgery Part B-Skull Base

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations

(2013) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma

(2013) Jinhua Wang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

(2013) Priscilla K Brastianos et al.   NATURE GENETICS

The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells

(2013) L. Fang et al.   NEURO-ONCOLOGY

Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas

(2013) Patrícia Henriques Domingues et al.   PLoS One

Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO

(2013) V. E. Clark et al.   SCIENCE

Immunophenotypic Identification and Characterization of Tumor Cells and Infiltrating Cell Populations in Meningiomas

(2012) Patrícia H. Domingues et al.   AMERICAN JOURNAL OF PATHOLOGY

Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

(2012) Esdy N. Rozali et al.   Clinical & Developmental Immunology

Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer

(2010) Lingyun Wei et al.   INTERNATIONAL JOURNAL OF CANCER

Epidemiology and etiology of meningioma

(2010) Joseph Wiemels et al.   JOURNAL OF NEURO-ONCOLOGY

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

(2010) Xingxing Zang et al.   MODERN PATHOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction

(2009) Judith Leitner et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

CD28 and CTLA-4 coreceptor expression and signal transduction

(2009) Christopher E. Rudd et al.   IMMUNOLOGICAL REVIEWS

Radiotherapy and radiosurgery for benign skull base meningiomas

(2009) Giuseppe Minniti et al.   Radiation Oncology